Regenerative Biomaterials, published by Oxford University Press, serves as a premier platform for the dissemination of innovative research in the rapidly evolving field of biomaterials. Since its inception in 2014, this esteemed open-access journal has fostered a collaborative and diverse scientific community, providing free access to impactful articles that enhance our understanding of regenerative medicine and tissue engineering. With a commendable impact factor and ranking within the top quartiles of both Biomedical Engineering and Materials Science, it is recognized for its rigorous peer-review process and high-quality publications. The journal aims to bridge the gap between fundamental research and applied sciences, promoting advanced studies that contribute to clinical applications and regeneration strategies. Researchers, practitioners, and students alike are encouraged to engage with the journal’s content to foster interdisciplinary collaboration and drive future innovations in the biomaterials domain.

Biomedical Engineering-Biomedizinische Technik, published by WALTER DE GRUYTER GMBH, serves as a pivotal platform for advancing knowledge in the field of biomedical engineering and medicine since its inception in 1956. With an ISSN of 0013-5585 and an E-ISSN of 1862-278X, this peer-reviewed journal offers accessible insights into innovative research and technological advancements that are reshaping healthcare practices and biomedical applications. Although rated in the Q3 category for both Biomedical Engineering and Miscellaneous Medicine in 2023, the journal's impact factor and growing reputation demonstrate its vital role in fostering academic dialogue and collaboration. The journal is based in Germany, while its scope encompasses a diverse range of topics, thus bridging the gap between engineering and medical disciplines. Researchers, professionals, and students alike are encouraged to engage with the content that not only highlights contemporary challenges but also presents groundbreaking solutions in biomedical technology.

Biomedical Materials, published by IOP Publishing Ltd, is a premier journal dedicated to the rapidly evolving field of biomedical engineering and materials science. With a robust impact factor showcasing its influence, this journal serves as a vital platform for disseminating pioneering research from 2006 to 2024. Covering an array of interdisciplinary topics—ranging from biomaterials to bioengineering and applied chemistry—the journal consistently ranks in the second quartile across multiple categories including Bioengineering (Q2), Biomaterials (Q2), and Biomedical Engineering (Q2) as of 2023. Researchers, professionals, and students alike benefit from its contributions, exploring innovative solutions at the intersection of biology and material science. Although not an Open Access journal, Biomedical Materials remains essential in advancing our understanding and facilitating discussions surrounding state-of-the-art materials that revolutionize medical applications and enhance patient care.

Materials Today Bio, published by Elsevier, is an esteemed open-access journal dedicated to advancing the fields of bioengineering, biomaterials, and biomedical engineering. Since its inception in 2019, this journal has quickly made a name for itself, currently ranked Q1 in multiple categories including Bioengineering, Biomaterials, and Biotechnology, reflecting its exceptional quality and relevance in the rapidly evolving landscape of bio-related sciences. With an impressive Scopus ranking positioning it in the top 25% of its categories, Materials Today Bio provides a vital platform for researchers and professionals to share cutting-edge discoveries and innovative applications that bridge the gap between materials science and biological studies. Accessible to a global audience, this journal not only fosters collaboration among the scientific community but also aims to highlight significant advancements in cell and molecular biology, making it an indispensable resource for students and seasoned experts alike. The journal's commitment to open access since 2019 underscores its dedication to disseminating knowledge widely, ensuring that crucial findings reach those who can benefit from them the most.

APL Bioengineering is a premier open-access journal published by AIP Publishing, dedicated to advancing the field of bioengineering and its interdisciplinary applications. Established in 2017, this journal serves as a vital platform for researchers, professionals, and students interested in the critical intersections of bioengineering, biomaterials, biomedical engineering, and biophysics. With an impressive impact factor and consistent rankings in the Q1 category across multiple domains, including biochemistry and materials science, APL Bioengineering has positioned itself among the top journals in its field. The journal aims to publish innovative original research, comprehensive reviews, and insightful case studies that further the understanding and application of bioengineering principles. Since its inception, APL Bioengineering has fostered a community of thought leaders, providing open access to ensure broad dissemination of knowledge and advancements that underpin the future of biomedical innovation.

Regenerative Medicine, published by Taylor & Francis Ltd, is a pivotal journal within the field of biomedical research, focusing on the innovative advances in regenerative and restored functions in human health. With an ISSN of 1746-0751 and an E-ISSN of 1746-076X, this esteemed journal boasts a commendable impact factor within its categories, notably holding the Q2 status in Embryology and Q3 in Biomedical Engineering as of 2023. Covering a broad spectrum of topics from stem cell research to tissue engineering, it serves as a crucial platform for interdisciplinary collaboration among researchers, professionals, and students dedicated to the regeneration of tissues and organs. Given its comprehensive scope from 2006 to 2024, the journal continues to attract high-quality manuscripts that advance the frontiers of knowledge in regenerative medicine. Researchers and practitioners alike are encouraged to engage with the latest findings and methodologies disseminated in this vital publication.

ANNALS OF BIOMEDICAL ENGINEERING is a premier journal in the field of biomedical engineering, published by Springer. Established in 1972, this journal has become a vital resource for researchers, professionals, and students engaged in the rapidly evolving domain of biomedical technology. With a commendable impact factor and ranked in the 76th percentile among its peers as per Scopus, it exemplifies excellence in disseminating critical research findings. The journal covers a broad scope of topics related to the integration of engineering principles with medical and biological sciences, facilitating innovations that enhance healthcare outcomes. Although open access is not offered in this journal, it remains an essential platform for scholarly communication, contributing to the continuous advancement of knowledge in biomedical engineering. ANNALS OF BIOMEDICAL ENGINEERING is not only a bridge for academics to share groundbreaking research but also an influential guide for practical applications in medicine and health technologies, making it a fundamental publication for its readership.

Frontiers in Bioengineering and Biotechnology, published by FRONTIERS MEDIA SA in Switzerland, stands as a leading platform for innovative research and developments in the fields of bioengineering and biotechnology. Since its inception in 2013, this Open Access journal has garnered significant recognition, reflected in its impressive category rankings: Q1 in Biomedical Engineering and Q2 in Bioengineering, Biotechnology, and Histology for 2023. With a focus on fostering collaboration and knowledge sharing, it aims to provide researchers, professionals, and students with access to pioneering studies that push the boundaries of science and technology. The journal, which is indexed in prominent databases, boasts high visibility and impact, evidenced by its impressive rankings across various categories in Scopus. As it continues to converge from 2013 to 2024, Frontiers in Bioengineering and Biotechnology is dedicated to shaping the discourse in its field and promoting advancements that have the potential to transform healthcare and environmental sustainability.

BME Frontiers, published by the American Association for the Advancement of Science, is an innovative open-access journal dedicated to the burgeoning field of Biomedical Engineering. Since its establishment in 2020, this journal has aimed to bridge the gap between cutting-edge research and practical application, promoting advancements in biomedical technologies, medical devices, and healthcare solutions. Boasting impressive rankings within Scopus—64th among 398 in Medicine (miscellaneous) and 81st among 303 in Biomedical Engineering—BME Frontiers stands out as a significant contributor to scholarly communication, offering rich insights for researchers, professionals, and students alike. With consistent publication projected through 2024, the journal serves as an essential platform for disseminating high-quality research that can drive innovation and inspire new approaches in the healthcare sector.

JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A, published by WILEY, is a leading journal in the field of biomaterials and biomedical engineering, showcasing cutting-edge research that bridges the gap between material science and healthcare applications. With a robust 2023 impact factor reflecting its high-quality contributions, this journal is classified in the Q2 quartile for Biomaterials, Biomedical Engineering, and Ceramics and Composites, while achieving an impressive Q1 ranking in Metals and Alloys. The journal caters to a diverse readership, including researchers, professionals, and students, aiming to facilitate innovation and advancements in biocompatible materials and their applications in medical devices and tissue engineering. Access options for readers are available, ensuring the latest studies and findings are readily accessible to all stakeholders in this dynamic field. As it progresses towards its 2024 target, the JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A continues to be an essential resource for anyone involved in the development and application of biomedical materials.